Loading...
Dernières publications
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
Ekaterina Kiseleva, Olesya Serbina, Anna Karpukhina, Vincent Mouly, Yegor S Vassetzky. Interaction between mesenchymal stem cells and myoblasts in the context of facioscapulohumeral muscular dystrophy contributes to the disease phenotype. Journal of Cellular Physiology, 2022, 237 (8), pp.3328-3337. ⟨10.1002/jcp.30789⟩. ⟨hal-03796151⟩
-
Muhammad Haseeb Iqbal, Jeanne Rosine Faratiana, Emeline Pradel, Varvara Gribova, Kamel Mamchaoui, et al.. Brush-Induced Orientation of Collagen Fibers in Layer-by-Layer Nanofilms: A Simple Method for the Development of Human Muscle Fibers. ACS Nano, In press, ⟨10.1021/acsnano.2c06329⟩. ⟨hal-03832239⟩
Chiffres clés
51
Publications avec texte intégral
Open Access
87 %
Mots clés
Atrial cardiac defects
ITSN1
Expanded repeats
Chromatin
Endocytosis
3D co-culture
Glucocorticoid-induced muscle atrophy
Myotonic dystrophy
Myotube
Skeletal muscle
Dystrophin
DiPRO1
Duchenne Muscular Dystrophy
DsDNA break repair
Coculture
FSHD
Neuromuscular disease
KLF15
Immortalized dystrophic canine myoblast
DMD
Becker muscular dystrophy
Lamina-associated domain
Cell Therapy
Fibroblast
Autophagosome
Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS
Computer software
Glucose
Lamin A/C nuclei
Allele-specific silencing therapy
Fear response
Differentiation
Exon Skipping
CXCR4
Human artificial chromosomes
Exon-skipping
Bile acid
BAF
Centronuclear myopathy
Human muscle stem/progenitor cells
Clinical trial candidate screening
Exon skipping
Cell biology
Folding-defective proteins
DNM2
Drisapersen
HDMD/Dmd-null mice
Gut microbiota
CXCL12
Muscle
Adhesion
Acetylcholine receptor subunit epsilon
CLS
Eteplirsen
Insulin
CMS
Dominant centronuclear myopathy
Duchenne muscular dystrophy
Allele-specific silencing
ICU-acquired weakness
Actin
Biomimetism
Adeno-associated viral vector
Neuromuscular junction
LTβR
Bioinformatics
Laminographie
BMD
DM1 myoblasts
Flavonoid
Gene Therapy
Myogenesis
Alternative splicing
Gene therapy
CFTR correctors
Antisense morpholino
CDNA synthesis
Motor neuron
Exondys 51
Dynamin 2
Genetics
Gel electrophoresis
RNA interference
FoxO
LRP4
Migration
Fibrosis
Immortalisation
Conjugation
CRISPR/Cas9
Developmental biology
CTG⋅CAGn repeat
Emerin
Antisense oligonucleotide
Human
Canine X-linked muscular dystrophy in Japan CXMD J
Culture platform
Gene network analysis
Autophagy
Cell-penetrating peptide